nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

01.06.2012 | Review Article

Pancreatic Neoplasia: A Practical Cross-sectional Imaging Primer for the Nonradiologist

verfasst von: Matthew T. Heller, Nathan Johnson, Antonio Fargiano

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this article is to provide a practical review of basic pancreatic imaging protocols and key cross-sectional imaging findings of the more common pancreatic neoplasms.

Methods

We performed a literature search and reviewed numerous cases archived in the radiology department of a large university hospital to find examples which illustrate the key cross-sectional imaging findings of pancreatic neoplasms.

Results

We reviewed the literature and provided several practical examples of common cross-sectional imaging findings in patients with pancreatic neoplasms.

Conclusions

Cross-sectional imaging plays a pivotal role in the evaluation of pancreatic neoplasms and allows proper triage of patients for conservative, medical or surgical management due to its ability to reliably detect and characterize pancreatic lesions, determine involvement of local structures, and assess metastatic disease. Familiarity with the key imaging findings will allow the clinician to better implement imaging data into daily practice.

Goshima S, Kanematsu M, Kondo H, Yokoyama R, Miyoshi T, et al. Pancreas: optimal scan delay for contrast-enhanced multi-detector row CT. Radiology. 2006;241:167–74.PubMedCrossRef

Kondo H, Kanematsu M, Goshima S, Miyoshi T, Shiratori Y, et al. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement. AJR Am J Roentgenol. 2007;188:751–6.PubMedCrossRef

Sheridan MB, Ward J, Guthrie JA, Spencer JA, Craven CM, et al. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol. 1999;173:583–90.PubMed

Nishiharu T, Yamashita Y, Abe Y, Mitsuzaki K, Tsuchigame T, et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging—ROC analysis. Radiology. 1999;212:445–52.PubMed

Schima W, Fugger R, Schober E, Oettl C, Wamser P, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol. 2002;179:717–24.PubMed

Brugge WR. The role of EUS in the diagnosis of cystic lesions of the pancreas. Gastrointest Endosc. 2000;52:S18–22.PubMedCrossRef

Lee TY, Kim MH, Park do H, Seo DW, Lee SK, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193:343–8.PubMedCrossRef

Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg. 2005;242:235–43.PubMedCrossRef

Kauhanen SP, Komar G, Seppanen MP, Dean KI, Minn HR, et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg. 2009;250:957–63.PubMedCrossRef

10.

Fontham ET, Correa P. Epidemiology of pancreatic cancer. Surg Clin North Am. 1989;69:551–67.PubMed

11.

Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, et al. Collective review of small carcinomas of the pancreas. Ann Surg. 1986;203:77–81.PubMedCrossRef

12.

Megibow AJ, Zhou XH, Rotterdam H, Francis IR, Zerhouni EA, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability—report of the Radiology Diagnostic Oncology Group. Radiology. 1995;195:327–32.PubMed

13.

McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, et al. Multi–detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology. 2001;220:97–102.PubMed

14.

Boland GW, O’Malley ME, Saez M, Fernandez-del-Castillo C, Warshaw AL, et al. Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol. 1999;172:605–8.PubMed

15.

Bonaldi VM, Bret PM, Atri M, Garcia P, Reinhold C. A comparison of two injection protocols using helical and dynamic acquisitions in CT examinations of the pancreas. AJR Am J Roentgenol. 1996;167:49–55.PubMed

16.

Keogan MT, Tyler D, Clark L, Branch MS, McDermott VG, et al. Diagnosis of pancreatic carcinoma: role of FDG PET. AJR Am J Roentgenol. 1998;171:1565–70.PubMed

17.

Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol. 1997;168:1439–43.PubMed

18.

Campbell F, Azadeh B. Cystic neoplasms of the exocrine pancreas. Histopathology. 2008;52:539–51.PubMedCrossRef

19.

Federle MP, McGrath KM. Cystic neoplasms of the pancreas. Gastroenterol Clin North Am. 2007;36:365–76. ix.PubMedCrossRef

20.

Sidden CR, Mortele KJ. Cystic tumors of the pancreas: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR. 2007;28:339–56.PubMedCrossRef

21.

Cohen-Scali F, Vilgrain V, Brancatelli G, Hammel P, Vullierme MP, et al. Discrimination of unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma with CT: initial observations. Radiology. 2003;228:727–33.PubMedCrossRef

22.

McGrath KM, Krasinskas AM, Federle MP. Intraductal papillary mucinous neoplasia. Gastroenterol Clin North Am. 2007;36:377–90. ix-x.PubMedCrossRef

23.

Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR. MR imaging of cystic lesions of the pancreas. Radiographics. 2009;29:1749–65.PubMedCrossRef

24.

Procacci C, Carbognin G, Biasiutti C, Guarise A, Ghirardi C, et al. Intraductal papillary mucinous tumors of the pancreas: spectrum of CT and MR findings with pathologic correlation. Eur Radiol. 2001;11:1939–51.PubMedCrossRef

25.

Coleman KM, Doherty MC, Bigler SA. Solid-pseudopapillary tumor of the pancreas. Radiographics. 2003;23:1644–8.PubMedCrossRef

26.

Madan AK, Weldon CB, Long WP, Johnson D, Raafat A. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004;85:193–8.PubMedCrossRef

27.

Cantisani V, Mortele KJ, Levy A, Glickman JN, Ricci P, et al. MR imaging features of solid pseudopapillary tumor of the pancreas in adult and pediatric patients. AJR Am J Roentgenol. 2003;181:395–401.PubMed

28.

Adsay NV, Klimstra DS. Cystic forms of typically solid pancreatic tumors. Semin Diagn Pathol. 2000;17:81–8.PubMed

29.

Solcia E, Sessa F, Rindi G, Villani L, Riva C, et al. Classification and histogenesis of gastroenteropancreatic endocrine tumours. Eur J Clin Invest. 1990;20 Suppl 1:S72–81.PubMed

30.

Kloppel G, Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract. 1988;183:155–68.PubMedCrossRef

31.

Buetow PC, Parrino TV, Buck JL, Pantongrag-Brown L, Ros PR, et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol. 1995;165:1175–9.PubMed

32.

Van Hoe L, Gryspeerdt S, Marchal G, Baert AL, Mertens L. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR Am J Roentgenol. 1995;165:1437–9.PubMed

33.

Huai JC, Zhang W, Niu HO, Su ZX, McNamara JJ, et al. Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg. 1998;175:18–21.PubMedCrossRef

Titel: Pancreatic Neoplasia: A Practical Cross-sectional Imaging Primer for the Nonradiologist
verfasst von: Matthew T. Heller
Nathan Johnson
Antonio Fargiano
Publikationsdatum: 01.06.2012
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 2/2012
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-010-9250-0

Neu im Fachgebiet Onkologie

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Pancreatic Neoplasia: A Practical Cross-sectional Imaging Primer for the Nonradiologist

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Onkologie

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2012

Ghrelin- and Serotonin-Producing Gastric Carcinoid

Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose

Prospective Phase I Study of Capecitabine and Oxaliplatin Concurrent with Radiation Therapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma, and Retrospective Comparison to Concurrent 5-Fluorouracil/Radiation and Gemcitabine/Radiation

Colorectal Cancer Screening in Women with Endometrial Cancer: Are We Following the Guidelines?

Evaluation of CA 242 as a Tumor Marker in Gallbladder Cancer

Cost-Effectiveness of Gemcitabine + Cisplatin vs. Gemcitabine Monotherapy in Advanced Biliary Tract Cancer

Neu im Fachgebiet Onkologie

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Onkologie